151 related articles for article (PubMed ID: 38129873)
1. Significantly reduced incidence and improved survival from prostate cancer over 25 years.
Serdà-Ferrer BC; Sanvisens A; Fuentes-Raspall R; Puigdemont M; Farré X; Vidal-Vila A; Rispau-Pagès M; Baltasar-Bagué A; Marcos-Gragera R
BMC Public Health; 2023 Dec; 23(1):2552. PubMed ID: 38129873
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
3. Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study.
Baeyens-Fernández JA; Molina-Portillo E; Pollán M; Rodríguez-Barranco M; Del Moral R; Arribas-Mir L; Sánchez-Cantalejo Ramírez E; Sánchez MJ
BMC Cancer; 2018 Aug; 18(1):781. PubMed ID: 30068302
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.
Innos K; Baburin A; Kotsar A; Eiche IE; Lang K
Scand J Urol; 2017 Dec; 51(6):442-449. PubMed ID: 29092653
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years.
García-Velasco A; Zacarías-Pons L; Teixidor H; Valeros M; Liñan R; Carmona-Garcia MC; Puigdemont M; Carbajal W; Guardeño R; Malats N; Duell E; Marcos-Gragera R
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33352812
[TBL] [Abstract][Full Text] [Related]
6. Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN).
Pla C; Solans M; Ameijide A; Sanvisens A; Carulla M; Rojas MD; Alemán MA; Sáez-Lloret I; Díaz-Del-Campo C; Marcos-Navarro AI; Sainz-de-Aja L; Aizpurua-Atxega A; Lopez-de-Munain A; Sánchez MJ; Perucha J; Franch P; Chirlaque MD; Guevara M; Galceran J; Merino S; Marcos-Gragera R;
Front Oncol; 2022; 12():1046307. PubMed ID: 36508554
[TBL] [Abstract][Full Text] [Related]
7. Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study.
Chang-Chan DY; Ríos-Tamayo R; Rodríguez Barranco M; Redondo-Sánchez D; González Y; Marcos-Gragera R; Sánchez MJ
Clin Transl Oncol; 2021 Jul; 23(7):1429-1439. PubMed ID: 33433836
[TBL] [Abstract][Full Text] [Related]
8. Incidence of prostate cancer and net survival by grade in a geriatric population: A population-based study in a French administrative entity from 1991 to 2013.
Bellier A; Colonna M; Delafosse P; Seigneurin A
Cancer Epidemiol; 2018 Oct; 56():60-66. PubMed ID: 30048940
[TBL] [Abstract][Full Text] [Related]
9. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008-2013 from a population-based cancer registry.
Deloumeaux J; Bhakkan B; Eyraud R; Braud F; Manip M'Ebobisse N; Blanchet P; Brureau L
Cancer Causes Control; 2017 Nov; 28(11):1265-1273. PubMed ID: 28921374
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer trends in Latvia during 1990-2012: incidence, prevalence, mortality, and survival rates.
Plonis J; Bokums K; Cauce V; Miklasevics E; Vaganovs P; Irmejs A; Gardovskis J; Vjaters E
Medicina (Kaunas); 2014; 50(6):313-7. PubMed ID: 25541262
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer incidence and mortality in Navarre (Spain).
Etxeberria J; Guevara M; Moreno-Iribas C; Burgui R; Delfrade I; Floristán Y; Montesino M; Ardanaz E
An Sist Sanit Navar; 2018 Apr; 41(1):9-15. PubMed ID: 29358783
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract][Full Text] [Related]
14. Incidence, mortality and survival of prostate cancer in two municipalities with a high human development index in Mato Grosso, Brazil.
Evangelista FM; Melanda FN; Modesto VC; Soares MR; Neves MABD; Souza BDSN; Sousa NFDSE; Galvão ND; Andrade ACS
Rev Bras Epidemiol; 2022; 25(Supl 1):e220016. PubMed ID: 35766773
[TBL] [Abstract][Full Text] [Related]
15. Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).
Auñón C; Sanvisens A; Turon E; Vidal-Vila A; Puigdemont M; Osca-Gelis G; Eraso A; Marcos-Gragera R
Cancer Med; 2023 Jun; 12(11):12343-12353. PubMed ID: 37076996
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
17. Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain.
López-Abente G; Mispireta S; Pollán M
BMC Cancer; 2014 Nov; 14():874. PubMed ID: 25421124
[TBL] [Abstract][Full Text] [Related]
18. Recent trends in prostate cancer in Spain.
Cayuela L; Lendínez-Cano G; Chávez-Conde M; Rodríguez-Domínguez S; Cayuela A
Actas Urol Esp (Engl Ed); 2020 Sep; 44(7):483-488. PubMed ID: 32600879
[TBL] [Abstract][Full Text] [Related]
19. Incidence of prostate cancer in Eritrea: Data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018.
Medhin LB; Achila OO; Syum BE; Gebremichael KH; Said SM; Lobeck H; Ghidei YT
PLoS One; 2020; 15(4):e0232091. PubMed ID: 32324838
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
